title: Preoperative cardiac risk stratification 2007: evolving evidence, evolving strategies.
abstract: Various guidelines and risk indices have optimized cardiac risk stratification, and the emphasis has shifted to reducing perioperative risk. This review is an update on invasive (CABG/PCI) and noninvasive (medical therapy with beta-blockers, alpha-agonists, and statins) strategies to reduce cardiac risk for noncardiac surgery and the controversies surrounding their use.
authors.affiliation: State University of New York-Downstate, Division of General Internal Medicine, Brooklyn, New York 11203, USA. steven.cohn@downstate.edu
authors.forename: Steven L
authors.initials: SL
authors.lastname: Cohn
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Auerbach
mesh_terms: D018663:Adrenergic Agents / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D006334:Heart Function Tests; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011300:Preoperative Care; D018570:Risk Assessment
chemical_list: D018663:Adrenergic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors